TLDR Compass Point analyst Ed Engel upgraded Circle (CRCL) from Sell to Neutral but lowered his price target from $75 to $60 Over 75% of USDC supply is used in TLDR Compass Point analyst Ed Engel upgraded Circle (CRCL) from Sell to Neutral but lowered his price target from $75 to $60 Over 75% of USDC supply is used in

Circle (CRCL) Stock: Wall Street Bear Upgrades Rating But Warns of Bank Competition

3 min read

TLDR

  • Compass Point analyst Ed Engel upgraded Circle (CRCL) from Sell to Neutral but lowered his price target from $75 to $60
  • Over 75% of USDC supply is used in DeFi or exchanges, making Circle’s stock move in lockstep with crypto markets rather than as a standalone fintech
  • USDC has shown a 0.66 correlation with ether since October’s market dip, with the trend expected to continue through mid-2026
  • USDC supply dropped 9% since December as competitors like USDH, CASH, and PYUSD take market share on platforms like Solana and Hyperliquid
  • Major banks including JPMorgan, State Street, and BNY Mellon are developing competing “deposit coins” that could challenge USDC in developed markets

Circle just got its second analyst upgrade in a week. This time from its harshest critic.


CRCL Stock Card
Circle Internet Group, CRCL

Compass Point’s Ed Engel moved Circle from Sell to Neutral on Thursday. He previously held the lowest price target among all analysts covering the stock. But don’t celebrate just yet.

His new price target sits at $60. That’s down from his previous $75 target. The stock closed Thursday at $67.55, down 7.3% during regular trading hours. It ticked up about 1% in after-hours trading.

Engel originally slapped a sell rating on Circle back in July. His beef? Growing competition in the stablecoin space. Now he says the market has already priced in most of those concerns.

The upgrade comes just one day after Mizuho’s Dan Dolev also revised his bearish stance. Two bears backing off in rapid succession raises eyebrows.

Trading Like Crypto, Not Fintech

Here’s the kicker. Engel isn’t upgrading because Circle got better. He’s upgrading because the stock changed character entirely.

Circle now trades as a crypto proxy rather than a fintech company. That’s a fundamental shift in how investors should view the stock.

Since October’s market dip, USDC has moved in lockstep with ether. The correlation stands at 0.66. Engel expects this pattern to stick around through mid-2026.

Why such tight correlation? More than 75% of all USDC sits in high-risk crypto trading or lending applications. The “stable” in stablecoin doesn’t mean the business is stable.

Circle’s revenue remains tightly linked to speculative crypto activity. This makes Circle a cyclical stock whether management likes it or not.

Regulatory Hope and Mounting Pressure

Engel sees a 60% chance the CLARITY Act passes in 2026. The legislation would provide clearer regulatory rules for stablecoins. That could support USDC supply growth.

Increased tokenization of U.S. stocks and ETFs in DeFi markets might help too. Even without regulatory approval, this trend could reduce Circle’s dependence on broader crypto sentiment.

But the competitive landscape is getting crowded fast. USDC supply has dropped 9% since December. Emerging stablecoins are eating into market share.

USDH, CASH, and PYUSD are gaining traction. They’re particularly strong on platforms like Solana and Hyperliquid.

Traditional finance is circling too. JPMorgan, State Street, and BNY Mellon are all developing “deposit coins.” These bank-issued competitors could directly challenge USDC in developed markets.

Engel also flagged another risk. Circle could guide 2026 operating expenses above Wall Street forecasts. Many of the company’s ongoing investments won’t generate meaningful revenue in the near term.

Despite the premium valuation concerns, Engel acknowledges some upside potential. If crypto markets rebound or regulation improves, the stock could benefit. But a true decoupling from crypto cycles could still be years away.

The analyst’s price target remains the lowest among all Wall Street analysts covering Circle.

The post Circle (CRCL) Stock: Wall Street Bear Upgrades Rating But Warns of Bank Competition appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29